Proximal for Burns

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Burns+2 More
pulsed dye laser - Procedure
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help determine if laser treatment can improve the appearance of scars from burns.

Eligible Conditions
  • Burns
  • Burn Scars

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: six months

six months
Scar Characteristics

Trial Safety

Trial Design

2 Treatment Groups

Proximal
1 of 2
Distal
1 of 2
Active Control

6 Total Participants · 2 Treatment Groups

Primary Treatment: Proximal · No Placebo Group · N/A

Proximal
Procedure
ActiveComparator Group · 1 Intervention: pulsed dye laser · Intervention Types: Procedure
Distal
Procedure
ActiveComparator Group · 1 Intervention: pulsed dye laser · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: six months

Who is running the clinical trial?

University of ManitobaLead Sponsor
537 Previous Clinical Trials
186,923 Total Patients Enrolled
5 Trials studying Burns
81 Patients Enrolled for Burns
S Logsetty, MDPrincipal InvestigatorUniversity of Manitoba
1 Previous Clinical Trials
6 Total Patients Enrolled
1 Trials studying Burns
6 Patients Enrolled for Burns

Eligibility Criteria

Age 18 - 65 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a scar age of one to six months.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 30th, 2021

Last Reviewed: October 31st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.